Cytek’s commitment to expanding access to advanced cytometry is a vital contribution to global public health. By supporting under-resourced labs, they’re helping ensure that essential research can ...
One huge reason why the world of medicine hasn't yet found "the cure" for hard-to-treat malignancies like acute myeloid ...
Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...
Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...
Slingshot Biosciences, the leader in precision-engineered cell mimic controls, announced a strategic collaboration with Cellares, the first Integrated Development and Manufacturing Organization (IDMO) ...
The UW Carbone Cancer Center and UW Biotechnology Center hosted the 8th annual BadgerConnect Research Services Fair Oct. 2 at ...
Affinity Technologies, Inc. , a biotechnology company advancing early-stage diagnostics including CyPath® Lung, the Company's noninvasive test for lung cancer, today announced that the Australian ...
Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they ...
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback